This study is currently not recruiting participants.

Modifiable Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women

Study of HPV (Human Papillomavirus) Infections in Kenyan Women

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to better understand the natural history of oncogenic HPV infections in HIV-infected and HIV-uninfected Kenyan women, including the potentially modifiable factors that are associated with progression of oncogenic HPV infection to clinical disease, including cervical cancer.

Detailed description of study

The purpose of this study is to better understand the natural history of oncogenic HPV infections in HIV-infected and HIV-uninfected Kenyan women, including the potentially modifiable factors that are associated with progression of oncogenic HPV infection to clinical disease, including cervical cancer.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: cervical cancer
  • Age: 100 years or below
  • Gender: All

The purpose of this study is to investigate the natural history of oncogenic HPV infections in Kenyan women, both those who are HIV-infected and those who are not. Oncogenic HPV refers to types of the human papillomavirus that can lead to cancer, such as cervical cancer. The study aims to identify factors that might influence the progression of these HPV infections to clinical diseases.

Participants in the study will undergo various procedures to monitor the HPV infection and its progression. These procedures might include regular health check-ups and laboratory tests to assess the status of the HPV infection and any related health changes.

  • Who can participate: The study is open to Kenyan women aged 18 and above who are either HIV-infected or HIV-uninfected.
  • Study details: Participants will be involved in health check-ups and laboratory tests to monitor the status of their HPV infection. An inactive substance, or placebo, may be used, which looks like the investigational medicine/vaccine but does not contain any medicine.
Updated on 19 Feb 2024. Study ID: 1409111068

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team